Entecavir (monohydrate)

Clear Filter

Results for "Entecavir (monohydrate)_Hs 766T": 729 gene sets

Name
Entecavir (monohydrate)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Entecavir (monohydrate)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Entecavir (monohydrate)_HS-578T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Entecavir (monohydrate)_HS-578T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Carbidopa (monohydrate)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Carbidopa (monohydrate)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxycycline (monohydrate)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxycycline (monohydrate)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Edoxaban (tosylate monohydrate)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Edoxaban (tosylate monohydrate)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Entecavir (monohydrate)_A-172 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Entecavir (monohydrate)_A-172 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Entecavir (monohydrate)_H4 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Entecavir (monohydrate)_H4 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Entecavir (monohydrate)_RPMI-7951 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Entecavir (monohydrate)_RPMI-7951 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Entecavir (monohydrate)_SW 900 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Entecavir (monohydrate)_SW 900 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Entecavir (monohydrate)_A498 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Entecavir (monohydrate)_A498 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Entecavir (monohydrate)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Entecavir (monohydrate)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Entecavir (monohydrate)_CHP-212 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Entecavir (monohydrate)_CHP-212 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Entecavir (monohydrate)_BT-474 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Entecavir (monohydrate)_BT-474 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Entecavir (monohydrate)_COLO 205 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Entecavir (monohydrate)_COLO 205 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Entecavir (monohydrate)_KATO III Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Entecavir (monohydrate)_KATO III drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Entecavir (monohydrate)_SW 1271 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Entecavir (monohydrate)_SW 1271 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Entecavir (monohydrate)_NCI-H596 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Entecavir (monohydrate)_NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Entecavir (monohydrate)_LOX-IMVI Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Entecavir (monohydrate)_LOX-IMVI drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Entecavir (monohydrate)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Entecavir (monohydrate)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Entecavir (monohydrate)_SW 1088 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Entecavir (monohydrate)_SW 1088 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Entecavir (monohydrate)_HEC-1-A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Entecavir (monohydrate)_HEC-1-A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Entecavir (monohydrate)_A549 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Entecavir (monohydrate)_A549 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Entecavir (monohydrate)_AsPC-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Entecavir (monohydrate)_AsPC-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Entecavir (monohydrate)_SW1417 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Entecavir (monohydrate)_SW1417 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Entecavir (monohydrate)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Entecavir (monohydrate)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Entecavir (monohydrate)_J82 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Entecavir (monohydrate)_J82 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Entecavir (monohydrate)_Panc 03.27 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Entecavir (monohydrate)_Panc 03.27 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Entecavir (monohydrate)_AN3 CA Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Entecavir (monohydrate)_AN3 CA drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Entecavir (monohydrate)_SHP-77 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Entecavir (monohydrate)_SHP-77 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Entecavir (monohydrate)_SNU-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Entecavir (monohydrate)_SNU-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Entecavir (monohydrate)_PANC-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Entecavir (monohydrate)_PANC-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Entecavir (monohydrate)_HOP62 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Entecavir (monohydrate)_HOP62 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Entecavir (monohydrate)_MIA PaCa-2 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Entecavir (monohydrate)_MIA PaCa-2 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Entecavir (monohydrate)_NCI-H23 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Entecavir (monohydrate)_NCI-H23 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Entecavir (monohydrate)_NCI-H661 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Entecavir (monohydrate)_NCI-H661 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Entecavir (monohydrate)_hTERT-HPNE Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Entecavir (monohydrate)_hTERT-HPNE drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Entecavir (monohydrate)_NCI-H1573 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Entecavir (monohydrate)_NCI-H1573 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Entecavir (monohydrate)_C-33 A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Entecavir (monohydrate)_C-33 A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Entecavir (monohydrate)_C32 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Entecavir (monohydrate)_C32 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Entecavir (monohydrate)_HT-29 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Entecavir (monohydrate)_HT-29 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Entecavir (monohydrate)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Entecavir (monohydrate)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Entecavir (monohydrate)_SK-MEL-2 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Entecavir (monohydrate)_SK-MEL-2 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Entecavir (monohydrate)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Entecavir (monohydrate)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Entecavir (monohydrate)_SW480 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Entecavir (monohydrate)_SW480 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Entecavir (monohydrate)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Entecavir (monohydrate)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Entecavir (monohydrate)_CFPAC-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Entecavir (monohydrate)_CFPAC-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Entecavir (monohydrate)_LoVo Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Entecavir (monohydrate)_LoVo drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Entecavir (monohydrate)_A-427 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Entecavir (monohydrate)_A-427 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Entecavir (monohydrate)_SW48 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Entecavir (monohydrate)_SW48 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Entecavir (monohydrate)_NCI-H2030 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Entecavir (monohydrate)_NCI-H2030 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Entecavir (monohydrate)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Entecavir (monohydrate)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Entecavir (monohydrate)_RKO Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Entecavir (monohydrate)_RKO drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Entecavir (monohydrate)_HCT15 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Entecavir (monohydrate)_HCT15 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxycycline (monohydrate)_HS-578T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxycycline (monohydrate)_HS-578T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Edoxaban (tosylate monohydrate)_HS-578T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Edoxaban (tosylate monohydrate)_HS-578T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_HS-578T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_HS-578T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Carbidopa (monohydrate)_HS-578T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Carbidopa (monohydrate)_HS-578T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Idarubicin (hydrochloride)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Idarubicin (hydrochloride)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tetracycline (hydrochloride)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tetracycline (hydrochloride)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
(R)-Verapamil (hydrochloride)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the (R)-Verapamil (hydrochloride)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lenalidomide (hemihydrate)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lenalidomide (hemihydrate)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pitavastatin (Calcium)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pitavastatin (Calcium)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Berberine (chloride hydrate)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Berberine (chloride hydrate)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lactate (calcium)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lactate (calcium)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cloxacillin (sodium)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cloxacillin (sodium)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bosentan (hydrate)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bosentan (hydrate)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Omeprazole (sodium)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Omeprazole (sodium)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Belumosudil (mesylate)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Belumosudil (mesylate)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pexidartinib (hydrochloride)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pexidartinib (hydrochloride)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Perindopril (erbumine)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Perindopril (erbumine)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxorubicin (hydrochloride)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxorubicin (hydrochloride)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rucaparib (phosphate)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rucaparib (phosphate)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bisoprolol (hemifumarate)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bisoprolol (hemifumarate)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Benproperine (phosphate)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Benproperine (phosphate)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Loperamide (hydrochloride)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Loperamide (hydrochloride)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Citalopram (hydrobromide)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Citalopram (hydrobromide)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bestatin (hydrochloride)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bestatin (hydrochloride)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Imiquimod (maleate)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Imiquimod (maleate)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ouabain (Octahydrate)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ouabain (Octahydrate)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Norepinephrine (hydrochloride)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Norepinephrine (hydrochloride)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fingolimod (hydrochloride)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fingolimod (hydrochloride)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Clonidine (hydrochloride)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Clonidine (hydrochloride)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Erdafitinib _Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Erdafitinib _Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lidocaine (hydrochloride)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lidocaine (hydrochloride)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lumateperone (tosylate)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lumateperone (tosylate)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Almonertinib (hydrochloride)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Almonertinib (hydrochloride)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Imiquimod (hydrochloride)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Imiquimod (hydrochloride)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Almonertinib (mesylate)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Almonertinib (mesylate)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cytarabine (hydrochloride)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cytarabine (hydrochloride)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Methyl aminolevulinate (hydrochloride)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Methyl aminolevulinate (hydrochloride)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pentamidine (isethionate)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pentamidine (isethionate)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rutin (trihydrate)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rutin (trihydrate)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Irinotecan (hydrochloride)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Irinotecan (hydrochloride)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tofacitinib (citrate)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tofacitinib (citrate)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Atazanavir (sulfate)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Atazanavir (sulfate)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Topotecan (hydrochloride)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Topotecan (hydrochloride)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Vinblastine (sulfate)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Vinblastine (sulfate)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Indacaterol (maleate)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Indacaterol (maleate)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Mitoxantrone (dihydrochloride)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Mitoxantrone (dihydrochloride)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Dapagliflozin ((2S)-1,2-propanediol, hydrate)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Dapagliflozin ((2S)-1,2-propanediol, hydrate)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Dorzolamide (hydrochloride)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Dorzolamide (hydrochloride)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tirabrutinib (hydrochloride)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tirabrutinib (hydrochloride)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Phenylephrine (hydrochloride)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Phenylephrine (hydrochloride)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Niclosamide (olamine)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Niclosamide (olamine)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
S-Adenosyl-L-methionine (disulfate tosylate)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the S-Adenosyl-L-methionine (disulfate tosylate)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Estrone sulfate (potassium)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Estrone sulfate (potassium)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cabozantinib (S-malate)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cabozantinib (S-malate)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Levobupivacaine (hydrochloride)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Levobupivacaine (hydrochloride)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Balsalazide (sodium hydrate)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Balsalazide (sodium hydrate)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Goserelin (acetate)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Goserelin (acetate)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pasireotide (acetate)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pasireotide (acetate)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Palmatine (chloride)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Palmatine (chloride)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Esmolol (hydrochloride)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Esmolol (hydrochloride)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Berbamine (dihydrochloride)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Berbamine (dihydrochloride)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Neratinib (maleate)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Neratinib (maleate)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rimonabant (Hydrochloride)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rimonabant (Hydrochloride)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
L-Thyroxine (sodium salt pentahydrate)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the L-Thyroxine (sodium salt pentahydrate)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Phenytoin (sodium)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Phenytoin (sodium)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Quinidine (15% dihydroquinidine)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Quinidine (15% dihydroquinidine)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
L-Eflornithine (monohydrochloride)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the L-Eflornithine (monohydrochloride)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pravastatin (sodium)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pravastatin (sodium)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Sivelestat (sodium tetrahydrate)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Sivelestat (sodium tetrahydrate)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Selinexor _Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Selinexor _Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Docetaxel (Trihydrate)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Docetaxel (Trihydrate)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Osimertinib (mesylate)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Osimertinib (mesylate)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Flumatinib (mesylate)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Flumatinib (mesylate)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pyridoxine (hydrochloride)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pyridoxine (hydrochloride)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cysteamine (hydrochloride)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cysteamine (hydrochloride)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Azithromycin (hydrate)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Azithromycin (hydrate)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Benztropine (mesylate)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Benztropine (mesylate)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Gallic acid (hydrate)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Gallic acid (hydrate)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ivabradine (hydrochloride)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ivabradine (hydrochloride)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fedratinib (hydrochloride hydrate)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fedratinib (hydrochloride hydrate)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Crizotinib (hydrochloride)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Crizotinib (hydrochloride)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fluvoxamine (maleate)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fluvoxamine (maleate)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
LY-2584702 (tosylate salt)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the LY-2584702 (tosylate salt)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Procainamide (hydrochloride)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Procainamide (hydrochloride)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Chlorhexidine (diacetate)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Chlorhexidine (diacetate)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Canagliflozin (hemihydrate)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Canagliflozin (hemihydrate)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Nafamostat (mesylate)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Nafamostat (mesylate)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Epirubicin (hydrochloride)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Epirubicin (hydrochloride)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fostamatinib (disodium hexahydrate)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fostamatinib (disodium hexahydrate)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
entecavir Gene Set From GeneRIF Biological Term Annotations genes co-occuring with the biological term entecavir in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset.
ENTECAVIR Gene Set From DGIdb Drug Targets 2026 interacting proteins for the ENTECAVIR drug from theDGIdb Drug Targets 2026 dataset.
Niclosamide (olamine)_HS-578T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Niclosamide (olamine)_HS-578T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tofacitinib (citrate)_HS-578T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tofacitinib (citrate)_HS-578T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Almonertinib (mesylate)_HS-578T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Almonertinib (mesylate)_HS-578T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Benproperine (phosphate)_HS-578T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Benproperine (phosphate)_HS-578T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Docetaxel (Trihydrate)_HS-578T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Docetaxel (Trihydrate)_HS-578T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lenalidomide (hemihydrate)_HS-578T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lenalidomide (hemihydrate)_HS-578T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
L-Thyroxine (sodium salt pentahydrate)_HS-578T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the L-Thyroxine (sodium salt pentahydrate)_HS-578T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Epirubicin (hydrochloride)_HS-578T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Epirubicin (hydrochloride)_HS-578T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Norepinephrine (hydrochloride)_HS-578T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Norepinephrine (hydrochloride)_HS-578T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lidocaine (hydrochloride)_HS-578T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lidocaine (hydrochloride)_HS-578T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Selinexor _HS-578T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Selinexor _HS-578T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Estrone sulfate (potassium)_HS-578T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Estrone sulfate (potassium)_HS-578T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bisoprolol (hemifumarate)_HS-578T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bisoprolol (hemifumarate)_HS-578T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Berbamine (dihydrochloride)_HS-578T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Berbamine (dihydrochloride)_HS-578T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Crizotinib (hydrochloride)_HS-578T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Crizotinib (hydrochloride)_HS-578T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Imiquimod (hydrochloride)_HS-578T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Imiquimod (hydrochloride)_HS-578T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Canagliflozin (hemihydrate)_HS-578T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Canagliflozin (hemihydrate)_HS-578T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bosentan (hydrate)_HS-578T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bosentan (hydrate)_HS-578T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rimonabant (Hydrochloride)_HS-578T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rimonabant (Hydrochloride)_HS-578T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tirabrutinib (hydrochloride)_HS-578T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tirabrutinib (hydrochloride)_HS-578T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Procainamide (hydrochloride)_HS-578T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Procainamide (hydrochloride)_HS-578T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Indacaterol (maleate)_HS-578T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Indacaterol (maleate)_HS-578T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Osimertinib (mesylate)_HS-578T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Osimertinib (mesylate)_HS-578T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Loperamide (hydrochloride)_HS-578T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Loperamide (hydrochloride)_HS-578T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lumateperone (tosylate)_HS-578T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lumateperone (tosylate)_HS-578T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pitavastatin (Calcium)_HS-578T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pitavastatin (Calcium)_HS-578T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Omeprazole (sodium)_HS-578T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Omeprazole (sodium)_HS-578T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pexidartinib (hydrochloride)_HS-578T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pexidartinib (hydrochloride)_HS-578T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cabozantinib (S-malate)_HS-578T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cabozantinib (S-malate)_HS-578T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cytarabine (hydrochloride)_HS-578T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cytarabine (hydrochloride)_HS-578T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Nafamostat (mesylate)_HS-578T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Nafamostat (mesylate)_HS-578T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fedratinib (hydrochloride hydrate)_HS-578T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fedratinib (hydrochloride hydrate)_HS-578T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cysteamine (hydrochloride)_HS-578T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cysteamine (hydrochloride)_HS-578T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rucaparib (phosphate)_HS-578T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rucaparib (phosphate)_HS-578T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Irinotecan (hydrochloride)_HS-578T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Irinotecan (hydrochloride)_HS-578T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
S-Adenosyl-L-methionine (disulfate tosylate)_HS-578T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the S-Adenosyl-L-methionine (disulfate tosylate)_HS-578T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
(R)-Verapamil (hydrochloride)_HS-578T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the (R)-Verapamil (hydrochloride)_HS-578T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Phenytoin (sodium)_HS-578T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Phenytoin (sodium)_HS-578T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rutin (trihydrate)_HS-578T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rutin (trihydrate)_HS-578T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Imiquimod (maleate)_HS-578T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Imiquimod (maleate)_HS-578T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Palmatine (chloride)_HS-578T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Palmatine (chloride)_HS-578T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Balsalazide (sodium hydrate)_HS-578T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Balsalazide (sodium hydrate)_HS-578T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Benztropine (mesylate)_HS-578T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Benztropine (mesylate)_HS-578T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Chlorhexidine (diacetate)_HS-578T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Chlorhexidine (diacetate)_HS-578T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Neratinib (maleate)_HS-578T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Neratinib (maleate)_HS-578T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cloxacillin (sodium)_HS-578T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cloxacillin (sodium)_HS-578T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Flumatinib (mesylate)_HS-578T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Flumatinib (mesylate)_HS-578T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Methyl aminolevulinate (hydrochloride)_HS-578T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Methyl aminolevulinate (hydrochloride)_HS-578T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fingolimod (hydrochloride)_HS-578T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fingolimod (hydrochloride)_HS-578T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Quinidine (15% dihydroquinidine)_HS-578T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Quinidine (15% dihydroquinidine)_HS-578T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Perindopril (erbumine)_HS-578T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Perindopril (erbumine)_HS-578T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Phenylephrine (hydrochloride)_HS-578T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Phenylephrine (hydrochloride)_HS-578T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Esmolol (hydrochloride)_HS-578T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Esmolol (hydrochloride)_HS-578T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Citalopram (hydrobromide)_HS-578T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Citalopram (hydrobromide)_HS-578T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Dapagliflozin ((2S)-1,2-propanediol, hydrate)_HS-578T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Dapagliflozin ((2S)-1,2-propanediol, hydrate)_HS-578T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Berberine (chloride hydrate)_HS-578T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Berberine (chloride hydrate)_HS-578T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Atazanavir (sulfate)_HS-578T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Atazanavir (sulfate)_HS-578T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fostamatinib (disodium hexahydrate)_HS-578T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fostamatinib (disodium hexahydrate)_HS-578T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Sivelestat (sodium tetrahydrate)_HS-578T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Sivelestat (sodium tetrahydrate)_HS-578T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Vinblastine (sulfate)_HS-578T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Vinblastine (sulfate)_HS-578T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Clonidine (hydrochloride)_HS-578T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Clonidine (hydrochloride)_HS-578T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tetracycline (hydrochloride)_HS-578T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tetracycline (hydrochloride)_HS-578T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pyridoxine (hydrochloride)_HS-578T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pyridoxine (hydrochloride)_HS-578T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxorubicin (hydrochloride)_HS-578T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxorubicin (hydrochloride)_HS-578T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Idarubicin (hydrochloride)_HS-578T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Idarubicin (hydrochloride)_HS-578T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pasireotide (acetate)_HS-578T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pasireotide (acetate)_HS-578T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Gallic acid (hydrate)_HS-578T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Gallic acid (hydrate)_HS-578T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Almonertinib (hydrochloride)_HS-578T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Almonertinib (hydrochloride)_HS-578T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ouabain (Octahydrate)_HS-578T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ouabain (Octahydrate)_HS-578T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Levobupivacaine (hydrochloride)_HS-578T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Levobupivacaine (hydrochloride)_HS-578T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pravastatin (sodium)_HS-578T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pravastatin (sodium)_HS-578T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lactate (calcium)_HS-578T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lactate (calcium)_HS-578T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ivabradine (hydrochloride)_HS-578T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ivabradine (hydrochloride)_HS-578T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Belumosudil (mesylate)_HS-578T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Belumosudil (mesylate)_HS-578T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Erdafitinib _HS-578T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Erdafitinib _HS-578T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fluvoxamine (maleate)_HS-578T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fluvoxamine (maleate)_HS-578T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Goserelin (acetate)_HS-578T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Goserelin (acetate)_HS-578T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
LY-2584702 (tosylate salt)_HS-578T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the LY-2584702 (tosylate salt)_HS-578T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bestatin (hydrochloride)_HS-578T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bestatin (hydrochloride)_HS-578T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Topotecan (hydrochloride)_HS-578T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Topotecan (hydrochloride)_HS-578T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Azithromycin (hydrate)_HS-578T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Azithromycin (hydrate)_HS-578T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Dorzolamide (hydrochloride)_HS-578T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Dorzolamide (hydrochloride)_HS-578T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
L-Eflornithine (monohydrochloride)_HS-578T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the L-Eflornithine (monohydrochloride)_HS-578T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pentamidine (isethionate)_HS-578T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pentamidine (isethionate)_HS-578T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Mitoxantrone (dihydrochloride)_HS-578T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Mitoxantrone (dihydrochloride)_HS-578T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
1,3-dihydroxy-2-hydroxymethylpropyl-2-ammonium 2-((R)-3-cyclo-hexyl-1-phenylpropyl)-1,3-dioxo-2,3-dihydro-1H-isoindole-5-carboxylate monohydrate Gene Set From CTD Gene-Chemical Interactions genes/proteins interacting with the chemical 1,3-dihydroxy-2-hydroxymethylpropyl-2-ammonium 2-((R)-3-cyclo-hexyl-1-phenylpropyl)-1,3-dioxo-2,3-dihydro-1H-isoindole-5-carboxylate monohydrate from the curated CTD Gene-Chemical Interactions dataset.
monohydrate Gene Set From GeneRIF Biological Term Annotations genes co-occuring with the biological term monohydrate in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset.
Carbidopa (monohydrate)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Carbidopa (monohydrate)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxycycline (monohydrate)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxycycline (monohydrate)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxycycline (monohydrate)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxycycline (monohydrate)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxycycline (monohydrate)_AN3 CA Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxycycline (monohydrate)_AN3 CA drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Edoxaban (tosylate monohydrate)_COLO 205 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Edoxaban (tosylate monohydrate)_COLO 205 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Edoxaban (tosylate monohydrate)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Edoxaban (tosylate monohydrate)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Carbidopa (monohydrate)_SW 900 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Carbidopa (monohydrate)_SW 900 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Edoxaban (tosylate monohydrate)_hTERT-HPNE Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Edoxaban (tosylate monohydrate)_hTERT-HPNE drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Carbidopa (monohydrate)_J82 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Carbidopa (monohydrate)_J82 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Carbidopa (monohydrate)_CFPAC-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Carbidopa (monohydrate)_CFPAC-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Carbidopa (monohydrate)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Carbidopa (monohydrate)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Edoxaban (tosylate monohydrate)_A-172 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Edoxaban (tosylate monohydrate)_A-172 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_A-172 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_A-172 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Carbidopa (monohydrate)_A-172 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Carbidopa (monohydrate)_A-172 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Carbidopa (monohydrate)_H4 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Carbidopa (monohydrate)_H4 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Edoxaban (tosylate monohydrate)_J82 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Edoxaban (tosylate monohydrate)_J82 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Carbidopa (monohydrate)_hTERT-HPNE Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Carbidopa (monohydrate)_hTERT-HPNE drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Edoxaban (tosylate monohydrate)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Edoxaban (tosylate monohydrate)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_J82 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_J82 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxycycline (monohydrate)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxycycline (monohydrate)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Carbidopa (monohydrate)_COLO 205 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Carbidopa (monohydrate)_COLO 205 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Edoxaban (tosylate monohydrate)_A498 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Edoxaban (tosylate monohydrate)_A498 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxycycline (monohydrate)_J82 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxycycline (monohydrate)_J82 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Carbidopa (monohydrate)_LoVo Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Carbidopa (monohydrate)_LoVo drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Carbidopa (monohydrate)_A498 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Carbidopa (monohydrate)_A498 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_KATO III Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_KATO III drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Edoxaban (tosylate monohydrate)_SW480 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Edoxaban (tosylate monohydrate)_SW480 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Carbidopa (monohydrate)_SW480 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Carbidopa (monohydrate)_SW480 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Edoxaban (tosylate monohydrate)_LoVo Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Edoxaban (tosylate monohydrate)_LoVo drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxycycline (monohydrate)_SW480 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxycycline (monohydrate)_SW480 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxycycline (monohydrate)_SK-MEL-2 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxycycline (monohydrate)_SK-MEL-2 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Edoxaban (tosylate monohydrate)_CHP-212 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Edoxaban (tosylate monohydrate)_CHP-212 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxycycline (monohydrate)_A-172 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxycycline (monohydrate)_A-172 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Edoxaban (tosylate monohydrate)_SW 1271 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Edoxaban (tosylate monohydrate)_SW 1271 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_H4 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_H4 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Carbidopa (monohydrate)_LOX-IMVI Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Carbidopa (monohydrate)_LOX-IMVI drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_SW 1271 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_SW 1271 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_SW1417 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_SW1417 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_AsPC-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_AsPC-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_A549 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_A549 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_LOX-IMVI Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_LOX-IMVI drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_RKO Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_RKO drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_NCI-H23 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_NCI-H23 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_CFPAC-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_CFPAC-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_NCI-H1573 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_NCI-H1573 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_C32 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_C32 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Carbidopa (monohydrate)_SW 1088 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Carbidopa (monohydrate)_SW 1088 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxycycline (monohydrate)_A549 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxycycline (monohydrate)_A549 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxycycline (monohydrate)_AsPC-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxycycline (monohydrate)_AsPC-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_SK-MEL-2 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_SK-MEL-2 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxycycline (monohydrate)_HEC-1-A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxycycline (monohydrate)_HEC-1-A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_Panc 03.27 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_Panc 03.27 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxycycline (monohydrate)_Panc 03.27 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxycycline (monohydrate)_Panc 03.27 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxycycline (monohydrate)_NCI-H1573 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxycycline (monohydrate)_NCI-H1573 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxycycline (monohydrate)_C32 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxycycline (monohydrate)_C32 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_A498 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_A498 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_AN3 CA Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_AN3 CA drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxycycline (monohydrate)_BT-474 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxycycline (monohydrate)_BT-474 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Edoxaban (tosylate monohydrate)_C-33 A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Edoxaban (tosylate monohydrate)_C-33 A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Carbidopa (monohydrate)_SW 1271 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Carbidopa (monohydrate)_SW 1271 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_HCT15 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_HCT15 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Carbidopa (monohydrate)_HCT15 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Carbidopa (monohydrate)_HCT15 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Carbidopa (monohydrate)_SW1417 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Carbidopa (monohydrate)_SW1417 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Carbidopa (monohydrate)_C32 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Carbidopa (monohydrate)_C32 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Edoxaban (tosylate monohydrate)_H4 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Edoxaban (tosylate monohydrate)_H4 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Carbidopa (monohydrate)_AN3 CA Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Carbidopa (monohydrate)_AN3 CA drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Carbidopa (monohydrate)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Carbidopa (monohydrate)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Edoxaban (tosylate monohydrate)_BT-474 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Edoxaban (tosylate monohydrate)_BT-474 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxycycline (monohydrate)_hTERT-HPNE Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxycycline (monohydrate)_hTERT-HPNE drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxycycline (monohydrate)_SW1417 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxycycline (monohydrate)_SW1417 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Carbidopa (monohydrate)_NCI-H661 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Carbidopa (monohydrate)_NCI-H661 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxycycline (monohydrate)_SW 900 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxycycline (monohydrate)_SW 900 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxycycline (monohydrate)_A498 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxycycline (monohydrate)_A498 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxycycline (monohydrate)_CHP-212 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxycycline (monohydrate)_CHP-212 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_BT-474 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_BT-474 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_SW480 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_SW480 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Edoxaban (tosylate monohydrate)_A549 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Edoxaban (tosylate monohydrate)_A549 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_NCI-H596 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Edoxaban (tosylate monohydrate)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Edoxaban (tosylate monohydrate)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_CHP-212 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_CHP-212 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Edoxaban (tosylate monohydrate)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Edoxaban (tosylate monohydrate)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_SW48 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_SW48 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Edoxaban (tosylate monohydrate)_AsPC-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Edoxaban (tosylate monohydrate)_AsPC-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Edoxaban (tosylate monohydrate)_RPMI-7951 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Edoxaban (tosylate monohydrate)_RPMI-7951 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Carbidopa (monohydrate)_KATO III Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Carbidopa (monohydrate)_KATO III drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Carbidopa (monohydrate)_HOP62 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Carbidopa (monohydrate)_HOP62 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_PANC-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_PANC-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_HEC-1-A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_HEC-1-A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Edoxaban (tosylate monohydrate)_PANC-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Edoxaban (tosylate monohydrate)_PANC-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_HT-29 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_HT-29 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Carbidopa (monohydrate)_PANC-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Carbidopa (monohydrate)_PANC-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_HOP62 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_HOP62 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxycycline (monohydrate)_CFPAC-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxycycline (monohydrate)_CFPAC-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxycycline (monohydrate)_LoVo Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxycycline (monohydrate)_LoVo drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Carbidopa (monohydrate)_NCI-H23 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Carbidopa (monohydrate)_NCI-H23 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Carbidopa (monohydrate)_RKO Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Carbidopa (monohydrate)_RKO drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Carbidopa (monohydrate)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Carbidopa (monohydrate)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Edoxaban (tosylate monohydrate)_LOX-IMVI Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Edoxaban (tosylate monohydrate)_LOX-IMVI drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxycycline (monohydrate)_RPMI-7951 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxycycline (monohydrate)_RPMI-7951 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxycycline (monohydrate)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxycycline (monohydrate)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxycycline (monohydrate)_MIA PaCa-2 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxycycline (monohydrate)_MIA PaCa-2 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_COLO 205 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_COLO 205 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Carbidopa (monohydrate)_MIA PaCa-2 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Carbidopa (monohydrate)_MIA PaCa-2 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Carbidopa (monohydrate)_SNU-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Carbidopa (monohydrate)_SNU-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_SNU-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_SNU-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Edoxaban (tosylate monohydrate)_Panc 03.27 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Edoxaban (tosylate monohydrate)_Panc 03.27 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Edoxaban (tosylate monohydrate)_SNU-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Edoxaban (tosylate monohydrate)_SNU-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxycycline (monohydrate)_SNU-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxycycline (monohydrate)_SNU-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Edoxaban (tosylate monohydrate)_AN3 CA Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Edoxaban (tosylate monohydrate)_AN3 CA drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Carbidopa (monohydrate)_NCI-H1573 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Carbidopa (monohydrate)_NCI-H1573 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Edoxaban (tosylate monohydrate)_SW1417 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Edoxaban (tosylate monohydrate)_SW1417 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxycycline (monohydrate)_SW 1271 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxycycline (monohydrate)_SW 1271 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxycycline (monohydrate)_HT-29 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxycycline (monohydrate)_HT-29 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxycycline (monohydrate)_HCT15 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxycycline (monohydrate)_HCT15 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxycycline (monohydrate)_PANC-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxycycline (monohydrate)_PANC-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Edoxaban (tosylate monohydrate)_HT-29 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Edoxaban (tosylate monohydrate)_HT-29 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Edoxaban (tosylate monohydrate)_SK-MEL-2 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Edoxaban (tosylate monohydrate)_SK-MEL-2 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Carbidopa (monohydrate)_HT-29 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Carbidopa (monohydrate)_HT-29 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxycycline (monohydrate)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxycycline (monohydrate)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxycycline (monohydrate)_NCI-H23 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxycycline (monohydrate)_NCI-H23 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Carbidopa (monohydrate)_SK-MEL-2 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Carbidopa (monohydrate)_SK-MEL-2 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Carbidopa (monohydrate)_A549 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Carbidopa (monohydrate)_A549 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxycycline (monohydrate)_A-427 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxycycline (monohydrate)_A-427 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Carbidopa (monohydrate)_NCI-H2030 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Carbidopa (monohydrate)_NCI-H2030 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxycycline (monohydrate)_HOP62 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxycycline (monohydrate)_HOP62 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Edoxaban (tosylate monohydrate)_NCI-H1573 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Edoxaban (tosylate monohydrate)_NCI-H1573 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Carbidopa (monohydrate)_AsPC-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Carbidopa (monohydrate)_AsPC-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Edoxaban (tosylate monohydrate)_SW48 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Edoxaban (tosylate monohydrate)_SW48 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Carbidopa (monohydrate)_BT-474 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Carbidopa (monohydrate)_BT-474 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxycycline (monohydrate)_LOX-IMVI Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxycycline (monohydrate)_LOX-IMVI drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Carbidopa (monohydrate)_SW48 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Carbidopa (monohydrate)_SW48 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Edoxaban (tosylate monohydrate)_HEC-1-A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Edoxaban (tosylate monohydrate)_HEC-1-A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Carbidopa (monohydrate)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Carbidopa (monohydrate)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxycycline (monohydrate)_H4 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxycycline (monohydrate)_H4 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Edoxaban (tosylate monohydrate)_RKO Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Edoxaban (tosylate monohydrate)_RKO drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxycycline (monohydrate)_C-33 A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxycycline (monohydrate)_C-33 A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_hTERT-HPNE Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_hTERT-HPNE drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxycycline (monohydrate)_RKO Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxycycline (monohydrate)_RKO drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_MIA PaCa-2 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_MIA PaCa-2 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxycycline (monohydrate)_SHP-77 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxycycline (monohydrate)_SHP-77 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Edoxaban (tosylate monohydrate)_SHP-77 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Edoxaban (tosylate monohydrate)_SHP-77 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Edoxaban (tosylate monohydrate)_HCT15 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Edoxaban (tosylate monohydrate)_HCT15 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Carbidopa (monohydrate)_CHP-212 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Carbidopa (monohydrate)_CHP-212 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Edoxaban (tosylate monohydrate)_NCI-H2030 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Edoxaban (tosylate monohydrate)_NCI-H2030 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_NCI-H661 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_NCI-H661 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxycycline (monohydrate)_NCI-H661 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxycycline (monohydrate)_NCI-H661 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Edoxaban (tosylate monohydrate)_SW 1088 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Edoxaban (tosylate monohydrate)_SW 1088 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Edoxaban (tosylate monohydrate)_HOP62 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Edoxaban (tosylate monohydrate)_HOP62 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Edoxaban (tosylate monohydrate)_C32 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Edoxaban (tosylate monohydrate)_C32 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Carbidopa (monohydrate)_HEC-1-A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Carbidopa (monohydrate)_HEC-1-A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_RPMI-7951 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_RPMI-7951 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxycycline (monohydrate)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxycycline (monohydrate)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Edoxaban (tosylate monohydrate)_KATO III Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Edoxaban (tosylate monohydrate)_KATO III drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_LoVo Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_LoVo drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Edoxaban (tosylate monohydrate)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Edoxaban (tosylate monohydrate)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Edoxaban (tosylate monohydrate)_SW 900 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Edoxaban (tosylate monohydrate)_SW 900 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Carbidopa (monohydrate)_SHP-77 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Carbidopa (monohydrate)_SHP-77 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Carbidopa (monohydrate)_Panc 03.27 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Carbidopa (monohydrate)_Panc 03.27 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Carbidopa (monohydrate)_A-427 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Carbidopa (monohydrate)_A-427 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_NCI-H2030 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_NCI-H2030 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Edoxaban (tosylate monohydrate)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Edoxaban (tosylate monohydrate)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxycycline (monohydrate)_NCI-H596 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxycycline (monohydrate)_NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Carbidopa (monohydrate)_NCI-H596 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Carbidopa (monohydrate)_NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Edoxaban (tosylate monohydrate)_CFPAC-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Edoxaban (tosylate monohydrate)_CFPAC-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxycycline (monohydrate)_KATO III Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxycycline (monohydrate)_KATO III drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Edoxaban (tosylate monohydrate)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Edoxaban (tosylate monohydrate)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxycycline (monohydrate)_SW48 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxycycline (monohydrate)_SW48 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_SW 900 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_SW 900 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Carbidopa (monohydrate)_RPMI-7951 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Carbidopa (monohydrate)_RPMI-7951 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxycycline (monohydrate)_COLO 205 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxycycline (monohydrate)_COLO 205 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_SW 1088 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_SW 1088 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_C-33 A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_C-33 A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Edoxaban (tosylate monohydrate)_A-427 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Edoxaban (tosylate monohydrate)_A-427 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_A-427 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_A-427 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_SHP-77 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_SHP-77 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Carbidopa (monohydrate)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Carbidopa (monohydrate)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Edoxaban (tosylate monohydrate)_NCI-H596 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Edoxaban (tosylate monohydrate)_NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Edoxaban (tosylate monohydrate)_NCI-H23 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Edoxaban (tosylate monohydrate)_NCI-H23 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Edoxaban (tosylate monohydrate)_MIA PaCa-2 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Edoxaban (tosylate monohydrate)_MIA PaCa-2 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxycycline (monohydrate)_SW 1088 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxycycline (monohydrate)_SW 1088 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Edoxaban (tosylate monohydrate)_NCI-H661 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Edoxaban (tosylate monohydrate)_NCI-H661 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxycycline (monohydrate)_NCI-H2030 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxycycline (monohydrate)_NCI-H2030 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Carbidopa (monohydrate)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Carbidopa (monohydrate)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Carbidopa (monohydrate)_C-33 A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Carbidopa (monohydrate)_C-33 A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxycycline (monohydrate)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxycycline (monohydrate)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
BOSUTINIB MONOHYDRATE Gene Set From DGIdb Drug Targets 2026 interacting proteins for the BOSUTINIB MONOHYDRATE drug from theDGIdb Drug Targets 2026 dataset.
NILOTINIB HYDROCHLORIDE MONOHYDRATE Gene Set From DGIdb Drug Targets 2026 interacting proteins for the NILOTINIB HYDROCHLORIDE MONOHYDRATE drug from theDGIdb Drug Targets 2026 dataset.
MOMELOTINIB DIHYDROCHLORIDE MONOHYDRATE Gene Set From DGIdb Drug Targets 2026 interacting proteins for the MOMELOTINIB DIHYDROCHLORIDE MONOHYDRATE drug from theDGIdb Drug Targets 2026 dataset.
LENALIDOMIDE HYDROCHLORIDE MONOHYDRATE Gene Set From DGIdb Drug Targets 2026 interacting proteins for the LENALIDOMIDE HYDROCHLORIDE MONOHYDRATE drug from theDGIdb Drug Targets 2026 dataset.
PEMETREXED MONOHYDRATE Gene Set From DGIdb Drug Targets 2026 interacting proteins for the PEMETREXED MONOHYDRATE drug from theDGIdb Drug Targets 2026 dataset.
SITAGLIPTIN HYDROCHLORIDE MONOHYDRATE Gene Set From DGIdb Drug Targets 2026 interacting proteins for the SITAGLIPTIN HYDROCHLORIDE MONOHYDRATE drug from theDGIdb Drug Targets 2026 dataset.
CISAPRIDE MONOHYDRATE Gene Set From DGIdb Drug Targets 2026 interacting proteins for the CISAPRIDE MONOHYDRATE drug from theDGIdb Drug Targets 2026 dataset.
DOXYCYCLINE MONOHYDRATE Gene Set From DGIdb Drug Targets 2026 interacting proteins for the DOXYCYCLINE MONOHYDRATE drug from theDGIdb Drug Targets 2026 dataset.
NIRAPARIB TOSYLATE MONOHYDRATE Gene Set From DGIdb Drug Targets 2026 interacting proteins for the NIRAPARIB TOSYLATE MONOHYDRATE drug from theDGIdb Drug Targets 2026 dataset.
DUVELISIB MONOHYDRATE Gene Set From DGIdb Drug Targets 2026 interacting proteins for the DUVELISIB MONOHYDRATE drug from theDGIdb Drug Targets 2026 dataset.
VELAGLIFLOZIN L-PROLINE MONOHYDRATE Gene Set From DGIdb Drug Targets 2026 interacting proteins for the VELAGLIFLOZIN L-PROLINE MONOHYDRATE drug from theDGIdb Drug Targets 2026 dataset.
HS 766T Gene Set From Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles genes with high or low copy number in HS 766T relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset.
HS 766T Gene Set From Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles genes with high or low expression in HS 766T relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles dataset.
HS 766T Gene Set From Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles genes mutated in the HS 766T cell line from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles dataset.
hs-766t cell Gene Set From TISSUES Text-mining Tissue Protein Expression Evidence Scores proteins co-occuring with the tissue hs-766t cell in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset.
Hs-766T Gene Set From Sanger Dependency Map Cancer Cell Line Proteomics proteins associated with the cell line Hs-766T from the Sanger Dependency Map Cancer Cell Line Proteomics dataset.
HS-766T cell Gene Set From TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 proteins co-occuring with the tissue HS-766T cell in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset.
Vitamin K4_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Vitamin K4_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Talc_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Talc_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Dihydroartemisinin_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Dihydroartemisinin_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Encorafenib_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Encorafenib_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Retinoic acid_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Retinoic acid_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
TAK-733_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the TAK-733_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Trametinib (DMSO_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Trametinib (DMSO_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Demeclocycline_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Demeclocycline_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
XRK3F2_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the XRK3F2_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Penfluridol_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Penfluridol_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Relugolix_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Relugolix_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
AT7519_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the AT7519_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bimiralisib_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bimiralisib_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Binimetinib_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Binimetinib_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Raltitrexed_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Raltitrexed_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Nevirapine_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Nevirapine_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Paclitaxel_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Paclitaxel_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Trametinib_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Trametinib_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Sulfisoxazole_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Sulfisoxazole_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
AZD-7648_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the AZD-7648_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tranilast_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tranilast_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Terfenadine_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Terfenadine_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Mifepristone_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Mifepristone_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Verteporfin_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Verteporfin_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
ULK-101_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the ULK-101_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rosiglitazone_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rosiglitazone_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cobimetinib_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cobimetinib_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
GSK1059615_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the GSK1059615_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Temsirolimus_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Temsirolimus_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Sunitinib_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Sunitinib_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Elimusertib hydrochloride_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Elimusertib hydrochloride_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Elagolix sodium_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Elagolix sodium_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Medroxyprogesterone acetate_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Medroxyprogesterone acetate_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Dexamethasone_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Dexamethasone_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bortezomib_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bortezomib_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
RMC-6236_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the RMC-6236_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ritonavir_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ritonavir_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Megestrol_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Megestrol_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tucidinostat_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tucidinostat_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Regorafenib_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Regorafenib_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Macitentan_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Macitentan_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
APTO-253_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the APTO-253_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
ERK5-IN-2_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the ERK5-IN-2_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tucatinib_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tucatinib_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Sodium Salicylate_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Sodium Salicylate_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ivermectin_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ivermectin_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Allopurinol_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Allopurinol_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cinacalcet_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cinacalcet_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Proglumide_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Proglumide_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Abiraterone acetate_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Abiraterone acetate_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
8-Hydroxyquinoline_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the 8-Hydroxyquinoline_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Adenine_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Adenine_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Afatinib_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Afatinib_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
palbociclib_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the palbociclib_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Voriconazole_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Voriconazole_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Aprepitant_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Aprepitant_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Vilanterol_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Vilanterol_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ribociclib_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ribociclib_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Hexylresorcinol_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Hexylresorcinol_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Methylthiouracil_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Methylthiouracil_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Glycyrrhizic acid_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Glycyrrhizic acid_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bexarotene_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bexarotene_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Neratinib_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Neratinib_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Resveratrol_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Resveratrol_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Orlistat_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Orlistat_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
LB-100_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the LB-100_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Celecoxib_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Celecoxib_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Volasertib_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Volasertib_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Posaconazole_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Posaconazole_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pemigatinib_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pemigatinib_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Docetaxel_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Docetaxel_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Triamcinolone_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Triamcinolone_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Omeprazole_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Omeprazole_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Darolutamide_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Darolutamide_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Clobetasol propionate_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Clobetasol propionate_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Clopidogrel_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Clopidogrel_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
SBI-0640756_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the SBI-0640756_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
AZD1390_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the AZD1390_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Gemfibrozil_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Gemfibrozil_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Radotinib_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Radotinib_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Amsacrine_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Amsacrine_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Clotrimazole_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Clotrimazole_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
EX229_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the EX229_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bergenin_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bergenin_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Trifluridine_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Trifluridine_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Belzutifan_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Belzutifan_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Sinomenine_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Sinomenine_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
NG25_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the NG25_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
MK-3903_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the MK-3903_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Saquinavir_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Saquinavir_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
c-Kit-IN-1_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the c-Kit-IN-1_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
BI-78D3_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the BI-78D3_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tubulin inhibitor 6_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tubulin inhibitor 6_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ixazomib_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ixazomib_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Artemether_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Artemether_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Olanzapine_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Olanzapine_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
γ-Oryzanol_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the γ-Oryzanol_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Harringtonine_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Harringtonine_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Panobinostat_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Panobinostat_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Budesonide_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Budesonide_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Betamethasone dipropionate_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Betamethasone dipropionate_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Baicalin_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Baicalin_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Adenosine_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Adenosine_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Trimetrexate_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Trimetrexate_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Dabrafenib_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Dabrafenib_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Furosemide_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Furosemide_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lapatinib ditosylate_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lapatinib ditosylate_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lucanthone_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lucanthone_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fumaric acid_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fumaric acid_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Finasteride_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Finasteride_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
(S)-Crizotinib_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the (S)-Crizotinib_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
DT-061_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the DT-061_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Plicamycin_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Plicamycin_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
5-Azacytidine_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the 5-Azacytidine_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Verapamil_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Verapamil_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Capivasertib_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Capivasertib_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lopinavir_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lopinavir_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pralsetinib_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pralsetinib_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Altretamine_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Altretamine_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Abemaciclib_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Abemaciclib_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
4EGI-1_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the 4EGI-1_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
NVP-BHG712_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the NVP-BHG712_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Asciminib_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Asciminib_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Eplerenone_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Eplerenone_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
OTS514_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the OTS514_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
PF-06260933_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the PF-06260933_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Brivudine_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Brivudine_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Oleic acid_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Oleic acid_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Oxaprozin_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Oxaprozin_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Acetazolamide_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Acetazolamide_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
LJI308_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the LJI308_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
olaparib_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the olaparib_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Malotilate_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Malotilate_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Captopril_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Captopril_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fulvestrant_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fulvestrant_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Naproxen_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Naproxen_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Econazole_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Econazole_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Hesperidin_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Hesperidin_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
LY2090314_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the LY2090314_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Meloxicam_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Meloxicam_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Sildenafil_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Sildenafil_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Uridine_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Uridine_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Darinaparsin_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Darinaparsin_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
PH-797804_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the PH-797804_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Carbamazepine_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Carbamazepine_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Busulfan_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Busulfan_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Canagliflozin_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Canagliflozin_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Acetohexamide_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Acetohexamide_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rapamycin_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rapamycin_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
5-Fluorouracil_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the 5-Fluorouracil_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Thymopentin_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Thymopentin_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tazarotene_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tazarotene_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cepharanthine_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cepharanthine_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Entrectinib_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Entrectinib_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Mebendazole_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Mebendazole_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
IQ 1_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the IQ 1_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
vincristine_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the vincristine_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Dinaciclib_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Dinaciclib_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Dexmedetomidine_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Dexmedetomidine_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rimonabant_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rimonabant_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Monocrotaline_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Monocrotaline_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Sapanisertib_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Sapanisertib_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Delamanid_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Delamanid_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Gallic acid_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Gallic acid_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
DTP3_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the DTP3_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Peretinoin_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Peretinoin_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Oxaliplatin_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Oxaliplatin_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
ETC-206_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the ETC-206_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cilostazol_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cilostazol_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Arbutin_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Arbutin_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Anethole trithione_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Anethole trithione_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Artesunate_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Artesunate_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Riluzole hydrochloride_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Riluzole hydrochloride_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Salicylic acid_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Salicylic acid_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Thymol_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Thymol_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Decitabine_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Decitabine_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pyridoxine_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pyridoxine_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Isocorydine_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Isocorydine_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Belumosudil_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Belumosudil_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
CP21R7_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the CP21R7_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Piroxicam_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Piroxicam_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Vortioxetine_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Vortioxetine_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Sonidegib_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Sonidegib_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pimozide_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pimozide_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Infigratinib_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Infigratinib_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Folic acid_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Folic acid_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Roxadustat_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Roxadustat_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ciclopirox_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ciclopirox_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Digitoxin_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Digitoxin_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pimitespib_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pimitespib_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pioglitazone_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pioglitazone_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Zileuton_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Zileuton_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Brimonidine_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Brimonidine_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tolmetin_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tolmetin_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Daidzin_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Daidzin_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Silodosin_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Silodosin_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Daptomycin_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Daptomycin_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Menadione_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Menadione_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Gemcitabine_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Gemcitabine_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tadalafil_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tadalafil_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Larotrectinib sulfate_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Larotrectinib sulfate_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ornidazole_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ornidazole_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Valdecoxib_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Valdecoxib_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
MK-8353_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the MK-8353_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Clofarabine_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Clofarabine_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Quinestrol_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Quinestrol_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Vismodegib_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Vismodegib_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Simotinib_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Simotinib_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ranolazine_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ranolazine_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ligustrazine_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ligustrazine_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fusidic acid_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fusidic acid_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Capmatinib_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Capmatinib_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Gefitinib_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Gefitinib_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Berbamine_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Berbamine_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Dapagliflozin_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Dapagliflozin_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Filgotinib_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Filgotinib_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cytarabine_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cytarabine_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cyclosporin A_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cyclosporin A_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Sulfatinib_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Sulfatinib_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Mozavaptan_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Mozavaptan_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fluvoxamine_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fluvoxamine_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fenofibrate_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fenofibrate_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Apalutamide_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Apalutamide_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Belinostat_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Belinostat_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ferulic acid_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ferulic acid_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Erlotinib_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Erlotinib_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Glasdegib_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Glasdegib_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tirabrutinib_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tirabrutinib_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Nimesulide_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Nimesulide_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
AZD-8055_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the AZD-8055_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
ML264_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the ML264_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Homoharringtonine_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Homoharringtonine_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Temuterkib_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Temuterkib_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Torkinib_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Torkinib_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tomivosertib_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tomivosertib_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
BAY1125976_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the BAY1125976_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Diphenhydramine_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Diphenhydramine_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Methotrexate_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Methotrexate_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Erythromycin_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Erythromycin_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Aspirin_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Aspirin_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Drospirenone_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Drospirenone_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Hydroxyurea_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Hydroxyurea_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bimatoprost_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bimatoprost_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Triclosan_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Triclosan_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Minodronic acid_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Minodronic acid_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rifaximin_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rifaximin_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pentagastrin_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pentagastrin_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bicalutamide_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bicalutamide_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Vandetanib_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Vandetanib_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Idoxuridine_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Idoxuridine_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tolcapone_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tolcapone_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Adagrasib_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Adagrasib_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lonafarnib_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lonafarnib_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Methylprednisolone succinate_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Methylprednisolone succinate_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Alpelisib_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Alpelisib_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
18β-Glycyrrhetinic acid_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the 18β-Glycyrrhetinic acid_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Everolimus_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Everolimus_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Hydroxyfasudil_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Hydroxyfasudil_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Larotrectinib_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Larotrectinib_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
TAK-901_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the TAK-901_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Flutamide_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Flutamide_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Dimethyl fumarate_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Dimethyl fumarate_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ralimetinib dimesylate_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ralimetinib dimesylate_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ponatinib_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ponatinib_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
venetoclax_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the venetoclax_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lipoic acid_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lipoic acid_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Irinotecan_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Irinotecan_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Futibatinib_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Futibatinib_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bentamapimod_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bentamapimod_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ipatasertib_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ipatasertib_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Diammonium Glycyrrhizinate_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Diammonium Glycyrrhizinate_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pemetrexed_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pemetrexed_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pentoxifylline_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pentoxifylline_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bendamustine_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bendamustine_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Anastrozole_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Anastrozole_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
BI-3406_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the BI-3406_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Vemurafenib_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Vemurafenib_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Auranofin_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Auranofin_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
AZD2858_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the AZD2858_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Aliskiren_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Aliskiren_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tofacitinib_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tofacitinib_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Allantoin_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Allantoin_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bestatin_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bestatin_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
crizotinib_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the crizotinib_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
9-ING-41_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the 9-ING-41_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ataluren_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ataluren_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ixazomib citrate_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ixazomib citrate_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
HI-TOPK-032_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the HI-TOPK-032_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.

Harmonizome 3.0

Entecavir (monohydrate)_Hs 766T Gene Set

Entecavir (monohydrate)_HS-578T Gene Set

Carbidopa (monohydrate)_Hs 766T Gene Set

Ropivacaine (hydrochloride monohydrate)_Hs 766T Gene Set

Doxycycline (monohydrate)_Hs 766T Gene Set

Edoxaban (tosylate monohydrate)_Hs 766T Gene Set

Entecavir (monohydrate)_A-172 Gene Set

Entecavir (monohydrate)_H4 Gene Set

Entecavir (monohydrate)_RPMI-7951 Gene Set

Entecavir (monohydrate)_SW 900 Gene Set

Entecavir (monohydrate)_A498 Gene Set

Entecavir (monohydrate)_NCI-H2347 Gene Set

Entecavir (monohydrate)_CHP-212 Gene Set

Entecavir (monohydrate)_BT-474 Gene Set

Entecavir (monohydrate)_COLO 205 Gene Set

Entecavir (monohydrate)_KATO III Gene Set

Entecavir (monohydrate)_SW 1271 Gene Set

Entecavir (monohydrate)_NCI-H596 Gene Set

Entecavir (monohydrate)_LOX-IMVI Gene Set

Entecavir (monohydrate)_NCI-H460 Gene Set

Entecavir (monohydrate)_SW 1088 Gene Set

Entecavir (monohydrate)_HEC-1-A Gene Set

Entecavir (monohydrate)_A549 Gene Set

Entecavir (monohydrate)_AsPC-1 Gene Set

Entecavir (monohydrate)_SW1417 Gene Set

Entecavir (monohydrate)_NCI-H1792 Gene Set

Entecavir (monohydrate)_J82 Gene Set

Entecavir (monohydrate)_Panc 03.27 Gene Set

Entecavir (monohydrate)_AN3 CA Gene Set

Entecavir (monohydrate)_SHP-77 Gene Set

Entecavir (monohydrate)_SNU-1 Gene Set

Entecavir (monohydrate)_PANC-1 Gene Set

Entecavir (monohydrate)_HOP62 Gene Set

Entecavir (monohydrate)_MIA PaCa-2 Gene Set

Entecavir (monohydrate)_NCI-H23 Gene Set

Entecavir (monohydrate)_NCI-H661 Gene Set

Entecavir (monohydrate)_hTERT-HPNE Gene Set

Entecavir (monohydrate)_NCI-H1573 Gene Set

Entecavir (monohydrate)_C-33 A Gene Set

Entecavir (monohydrate)_C32 Gene Set

Entecavir (monohydrate)_HT-29 Gene Set

Entecavir (monohydrate)_HepG2/C3A Gene Set

Entecavir (monohydrate)_SK-MEL-2 Gene Set

Entecavir (monohydrate)_LS 180 Gene Set

Entecavir (monohydrate)_SW480 Gene Set

Entecavir (monohydrate)_NCI-H2122 Gene Set

Entecavir (monohydrate)_CFPAC-1 Gene Set

Entecavir (monohydrate)_LoVo Gene Set

Entecavir (monohydrate)_A-427 Gene Set

Entecavir (monohydrate)_SW48 Gene Set

Entecavir (monohydrate)_NCI-H2030 Gene Set

Entecavir (monohydrate)_SNU-423 Gene Set

Entecavir (monohydrate)_RKO Gene Set

Entecavir (monohydrate)_HCT15 Gene Set

Doxycycline (monohydrate)_HS-578T Gene Set

Edoxaban (tosylate monohydrate)_HS-578T Gene Set

Ropivacaine (hydrochloride monohydrate)_HS-578T Gene Set

Carbidopa (monohydrate)_HS-578T Gene Set

Idarubicin (hydrochloride)_Hs 766T Gene Set

Tetracycline (hydrochloride)_Hs 766T Gene Set

(R)-Verapamil (hydrochloride)_Hs 766T Gene Set

Lenalidomide (hemihydrate)_Hs 766T Gene Set

Pitavastatin (Calcium)_Hs 766T Gene Set

Berberine (chloride hydrate)_Hs 766T Gene Set

Lactate (calcium)_Hs 766T Gene Set

Cloxacillin (sodium)_Hs 766T Gene Set

Bosentan (hydrate)_Hs 766T Gene Set

Omeprazole (sodium)_Hs 766T Gene Set

Belumosudil (mesylate)_Hs 766T Gene Set

Pexidartinib (hydrochloride)_Hs 766T Gene Set

Perindopril (erbumine)_Hs 766T Gene Set

Doxorubicin (hydrochloride)_Hs 766T Gene Set

Rucaparib (phosphate)_Hs 766T Gene Set

Bisoprolol (hemifumarate)_Hs 766T Gene Set

Benproperine (phosphate)_Hs 766T Gene Set

Loperamide (hydrochloride)_Hs 766T Gene Set

Citalopram (hydrobromide)_Hs 766T Gene Set

Bestatin (hydrochloride)_Hs 766T Gene Set

Imiquimod (maleate)_Hs 766T Gene Set